Janux公布在转移性去势抵抗性前列腺癌的I期临床试验中令人鼓舞的疗效和安全性数据
Janux公布在转移性去势抵抗性前列腺癌的I期临床试验中令人鼓舞的疗效和安全性数据
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.